All lobbying filings

TIBER CREEK GROUP

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 19, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 1

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.